Simplex Trading’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Simplex Trading’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$198K	Buy	+3,477	New	+$166K	﹤0.01%	4735
2024 Q4	–	Sell	-44	Closed	-$1K	–	8930
2024 Q3	$1K	Buy	44 +29	+193%	+$1.3K	﹤0.01%	8189
2024 Q2	$0	Buy	+15	New	+$627	﹤0.01%	9152
2022 Q4	–	Sell	-578	Closed	-$29K	–	9613
2022 Q3	$29K	Buy	578 +384	+198%	+$21.7K	﹤0.01%	7104
2022 Q2	$9K	Sell	194 -1,815	-90%	-$92K	﹤0.01%	8364
2022 Q1	$120K	Buy	2,009 +1,890	+1,588%	+$119K	﹤0.01%	5890
2021 Q4	$9K	Sell	119 -3	-2%	-$252	﹤0.01%	9115
2021 Q3	$12K	Hold	122	–	–	﹤0.01%	8815
2021 Q2	$12K	Buy	122 +82	+205%	+$7.27K	﹤0.01%	8979
2021 Q1	$3K	Buy	+40	New	+$3.95K	﹤0.01%	8363

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return

Simplex Trading's GNOM Position: Q2 2026 in Review

Simplex Trading opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q2 2026: 3,477 shares worth $198K. The stake represents ﹤0.01% of the portfolio and ranks #4735 among its holdings. This is a return to the name: Simplex Trading previously reported a position in GNOM as recently as Q3 2024.

Simplex Trading first reported a position in GNOM in Q1 2021 and has held it in 10 quarters since. 48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

Simplex Trading held 3,477 shares of Global X Genomics & Biotechnology ETF worth $198K as of Q2 2026.
Global X Genomics & Biotechnology ETF was a new Simplex Trading position in Q2 2026.
Global X Genomics & Biotechnology ETF made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4735 holding.
Simplex Trading first reported a position in Global X Genomics & Biotechnology ETF in Q1 2021 and has held it in 10 quarters since.
48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.